We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study.
- Authors
Sandahl, Thomas Damgaard; Grønbæk, Henning; Støy, Sidsel; Thomsen, Karen Luise; Dige, Anders Kirch; Agnholt, Jørgen; Vilstrup, Hendrik; Møller, Holger Jon; Hamilton-Dutoit, Stephen; Thiel, Steffen
- Abstract
OBJECTIVES:Inflammatory activation of resident hepatic macrophages (Kupffer cells) by portal-derived lipopolysaccharide (LPS) has a primary role in animal models of alcoholic liver disease, but it has not been systematically or longitudinally studied in human alcoholic hepatitis (AH).METHODS:We followed 50 patients with AH for 30 days. 26 patients with stable alcoholic cirrhosis and 20 healthy individuals were controls. We measured the plasma (P) concentrations of soluble CD163 (sCD163; a specific marker of inflammatory macrophage activation) and the expression of CD163 in liver tissue by immunohistochemistry and stereology of liver biopsies. We also measured the key components of the LPS pathway, P-LPS, sCD14, and LPS-binding protein (LBP), by enzyme-linked immunosorbent assay (ELISA). The 84-day mortality was registered.RESULTS:At study entry, the sCD163 concentration was 10-fold higher than in the healthy controls and 30% higher than in the stable cirrhotics (P<0.002), and it correlated with the Glasgow Alcoholic Hepatitis, Model for End-stage Liver Disease, and Child-Pugh scores (r>0.35, P<0.02, all). The liver biopsies confirmed markedly increased CD163 staining (P<0.01). P-LPS, P-CD14, and P-LBP were increased to the same degree as sCD163. During the follow-up, the sCD163 and LPS pathway components all decreased by ∼25% (P<0.05) but remained higher than in both control groups. sCD163 was an independent predictor of the 84-day mortality.CONCLUSIONS:The hepatic inflammation of human AH involves marked activation of hepatic macrophages, likely via the LPS pathway. Hepatic macrophages may thus present a target for biological therapy of AH.
- Subjects
MACROPHAGE activation; KUPFFER cells; HEPATITIS; LIVER diseases; DISEASES in people with alcoholism; INFLAMMATION; PATIENTS
- Publication
American Journal of Gastroenterology (Springer Nature), 2014, Vol 109, Issue 11, p1749
- ISSN
0002-9270
- Publication type
Article
- DOI
10.1038/ajg.2014.262